Resignation of Dr Warner as a director of Deterra
12 Two incidences of non-compliance with the Corporations Act arise under this application. The first is Deterra's failure to lodge the prescribed 'Form 484 - Change to Company Details' with ASIC in relation to Dr Joanne Warner's resignation as a director within the time required under s 205B(5).
13 Dr Warner was appointed as a non-executive director of Deterra on 16 October 2020. In December 2023 she communicated to the board her intention to resign with effect from 31 March 2024. A resignation letter was signed by Dr Warner on 18 December 2023. An ASX announcement was prepared by Ms Kerr, and approved by Deterra's managing director and chief executive officer, Mr Julian Andrews. The announcement was released to the ASX on 18 December 2023 and stated Dr Warner's retirement as being effective from 31 March 2024.
14 On 3 April 2024, Deterra released an ASX announcement titled 'Appendix 3Z - Final Director's Interest Notice', which included information required for the purposes of listing rule 3.19A.3 of the ASX Listing Rules and s 205G of the Corporations Act. That announcement also stated Dr Warner's retirement as effective from 31 March 2024.
15 Deterra did not, however, lodge a Form notifying ASIC of Dr Warner's resignation within the 28 days required by s 205B(5) of the Corporations Act. Ms Kerr is responsible for overseeing such requirements and deposes that this failure was an 'inadvertent, administrative oversight' on her behalf. She says that she ordinarily sets calendar reminders for any compliance actions within the prescribed timeframes, and it appears that she either failed to set the reminder to lodge the Form for Dr Warner's resignation, or accidentally dismissed the relevant reminder.
16 On 20 December 2023, Ms Kerr did cause a Form to be lodged in relation to a change of joint company secretary that had been announced to the ASX on the same day as the announcement of Dr Warner's resignation. Ms Kerr says that between 31 March and 3 July 2024, she did not turn her mind to Deterra's obligation to notify ASIC of Dr Warner's resignation.
17 The non-compliance was discovered on 3 July 2024, when Ms Kerr logged into the ASIC Regulatory Portal to review Deterra's Annual Company Statement and noticed that Dr Warner remained listed as a current director of Deterra. Upon seeing this, Ms Kerr immediately prepared and lodged a Form 484 with ASIC in respect of Dr Warner's resignation. This was recorded as having been received by ASIC on 3 July 2024 at 11.21 am. Therefore the date that Dr Warner's resignation took effect under the Corporations Act is currently 3 July 2024: s 203AA(1)(b).
18 On 4 July 2024, Ms Kerr instructed Deterra's solicitors, King & Wood Mallesons, in respect of the contravention of s 205B(5). The 56-day window to apply to ASIC to fix the resignation date had passed when the non-compliance was discovered. After obtaining Dr Warner's consent to the making of this application, the application was filed.
19 Ms Kerr deposes to the best of her knowledge and based on her correspondence with Dr Warner in March and April 2024, that at all times from close of business on 31 March 2024, Dr Warner has proceeded on the belief and understanding that her resignation took effect from 31 March 2024. Ms Kerr further says that at all times from close of business on 31 March 2024, Deterra has conducted its affairs on the basis that Dr Warner is no longer a director of Deterra. Ms Kerr says that since 31 March 2024, she has attended all formal meetings of Deterra's board of directors, and Dr Warner has not been invited to, nor has she attended, any of those meetings. Nor has Dr Warner performed any duties or participated in the functions of the board since 31 March 2024.
20 Ms Kerr also says that to the best of her knowledge, the orders sought in respect of Dr Warner's resignation, if made, will not cause prejudice to any third party.